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Abstract
Background. Reports of changes in patients’ social behavior during deep brain stimulation
(DBS) raised the question whether DBS induces changes in personality. This study explored
if (1) DBS is associated with changes in personality in patients suffering from treatment-resist-
ant depression (TRD), (2) how personality dimensions and depression are associated, and (3)
if TRD patients’ self-ratings of personality are valid.
Methods. TRD patients were assessed before DBS (n = 30), 6 months (t2, n = 21), 2 (t3,
n = 17) and 5 years (t4, n = 11) after the initiation of DBS of the supero-lateral branch of
the medial forebrain bundle (slMFB-DBS). Personality was measured with the NEO-Five-Fac-
tor Inventory (NEO-FFI), depression severity with Hamilton (HDRS), and Montgomery–
Åsberg Depression Rating Scale (MADRS).
Results. Personality dimensions did not change with slMFB-DBS compared with baseline.
Extraversion was negatively correlated with HDRS28 (r =−0.48, p < 0.05) and MADRS (r =
−0.45, p < 0.05) at t2. Inter-rater reliability was high for the NEO-FFI at baseline
(Cronbach’s α = 0.74) and at t4 (α = 0.65). Extraversion [t(29) =−5.20; p < 0.001] and openness
to experience [t(29) =−6.96; p < 0.001] differed statistically significant from the normative
sample, and did not predict the antidepressant response.
Conclusions. slMFB-DBS was not associated with a change in personality. The severity of
depression was associated with extraversion. Personality of TRD patients differed from the
healthy population and did not change with response, indicating a possible scar effect. Self-
ratings of personality seem valid to assess personality during TRD.
Introduction
A large number of depressive patients (33%) do not respond to an antidepressant treatment
even after more than four trials with conventional treatment methods (Rush et al. 2006).
For these patients suffering from treatment-resistant depression (TRD), deep brain stimulation
(DBS) is currently under research as a new treatment method. Different brain regions, namely
the subgenual cingulate cortex, the nucleus accumbens, the anterior limb of the capsule
interna, and the supero-lateral branch of the medial forebrain bundle (slMFB) have been sti-
mulated with antidepressant results in about 40–70% of the patients (Lozano et al. 2008;
Malone et al. 2009; Bewernick et al. 2010; Bewernick et al. 2012; Bewernick et al. 2017a, b).
There are individual reports of changes in the patients’ social behavior after the treatment
of Parkinson’s diseases with DBS of the subthalamic nucleus (STN) (Schüpbach et al. 2006;
Glannon, 2009; Pham et al. 2015). These observations raise the question, whether DBS can
induce changes in personality in TRD, but the relationship between DBS and personality
has not been assessed systematically until now. Probably, stimulation of different target sites
could influence personality uniquely, and thus the assessment of personality could be an
important aspect of the side-effect profile of the respective target. For example, the slMFB
as a key structure of the reward system (Coenen et al. 2012) could have a special influence
on extraversion.
It is obvious that the constructs of depression and personality
are overlapping and difficult to dissociate. Depression and per-
sonality are correlated, and it is known that depressive patients
score higher in neuroticism and lower in extraversion and con-
scientiousness compared with a healthy normative sample
(Kotov et al. 2010). Personality dimensions are discussed as a pre-
dictor for the antidepressant response (Huys et al. 2016), and
changes in the personality profile have been described in respon-
ders (Bagby et al. 2008).
Two hypotheses on the relationship of personality and depres-
sion are discussed: the ‘state model’ assumes transient, state-
dependent changes of personality related to the severity of depres-
sion. In the contrary, irreversible, long-term changes of personal-
ity after depressive episodes have been proposed in the ‘scar
model’ (Klein et al. 2011). Furthermore, it is debated that if the
patients are able to judge their personality validly during a depres-
sive episode (Bagby et al. 1998; Klein et al. 2011).
This study explored (1) how DBS of the slMFB is associated
with personality in patients suffering from TRD. Furthermore,
we investigated (2) the association between personality and
depression and treatment response and (3) compared patients’
self-ratings of personality with observer ratings to obtain informa-
tion on the validity of the self-ratings of depressive patients.
Methods and materials
Patients
At baseline, we included 30 patients suffering from TRD (13
females, 17 males, mean age 49 years). Patients were eligible for
inclusion if they were between 20 and 70 years of age and had
received a primary diagnosis of major depressive disorder
(MDD), determined according to the criteria of the Diagnostic
and Statistical Manual of Mental Disorders, Fourth Edition
[DSM-IV; assessed with Structured Clinical Interview after
DSM-IV SCID-I]. Selection criteria were a minimum score on
the 24-item Hamilton Depression Rating Scale (HDRS24) of 21
and a score in Global Assessment of Function (GAF) below 45.
Further inclusion criteria were at least four episodes of MDD or
chronic episodes over 2 years; more than 5 years after the first epi-
sode of MDD; failure to respond to adequate trials of primary
antidepressants from at least three different classes; adequate trials
of augmentation/combination of a primary antidepressant using
at least two different augmenting/combination agents; an
adequate trial of electroconvulsive therapy (more than six bilateral
treatments); an adequate trial of individual psychotherapy (more
than 20 sessions, cognitive behavioral therapy, cognitive behav-
ioral analysis system of psychotherapy); and no psychiatric
co-morbidity and drug-free or on stable drug regimen at least 6
weeks before study entry. Exclusion criteria were current or past
non-affective psychotic disorder; any current clinically significant
neurological disorder or medical illness affecting brain function,
or severe personality disorder (assessed with SCID-II). All
patients to be included in the study had severe TRD (for demo-
graphic details, see Table 1). Treatment resistance was assessed
with the antidepressant treatment history form (Sackeim, 2001).
At baseline, patients were included from three different stud-
ies: patients of the study FORESEE I (n = 7) were implanted in
the years 2011/2012 (registered at clinicaltrials.gov with the iden-
tifier NCT01095263), patients of the study FORESEE II (n = 16)
were implanted in the years 2014/2015 (registered at clinical-
trials.gov with the identifier NCT01778790), patients of the
study FORESEE III (n = 7) were not implanted yet, so that they
could only be included in the baseline analysis.
In the follow-up, several patients (n = 12) had to be excluded
from the analyses because DBS was stopped due to non-response
(n = 6) or because of non-compliance to answer the question-
naires (n = 5) and methylphenidat abuse (n = 1). In the last obser-
vation, 5 years after the onset of DBS, data of 11 patients could be
evaluated (Fig. 1).
Assessment and study protocol
The patients were assessed before DBS (baseline), 6 months after
the onset of DBS (t2), 2 years after the onset of DBS, (t3) and up
to 5 years after the onset of DBS (t4). Relatives were asked to rate
the personality of the patients at baseline (during the depressive
episode) retrospectively and at t4.
Data of 14 relatives or significant others could be included in
the baseline analyses, and data of nine relatives could be included
in the follow-up analyses at t4. The relatives were included in the
analysis because they knew patients better than, for example, the
investigator team and inter-rater reliability could be evaluated to
prevent a possible depression-induced rating bias (Bagby et al.
1998; Klein et al. 2011). Self- and observer personality ratings
are known to be highly correlated (Connolly et al. 2007).
Personality was measured with the German version of the
NEO-Five-Factor Inventory (NEO-FFI; Borkenau and Ostendorf,
2008). The NEO-FFI is a self-rating instrument. For the observer
Table 1. Demographic and clinical characteristics
Characteristic t1 (baseline) t2 (6 months) t3 (2 years) t4 (5 years)
Total (n) 30 21 17 11
Male (n) 17 13 11 7
Female (n) 13 8 6 4
Mean (S.D.) Mean (S.D.) Mean (S.D.) Mean (S.D.)
Age at implant (years) 47.33 (10.62) 49.33 (10.03) 49.18 (11.16) 49.18 (11.16)
Length of current episode (years) 8.57 (7.75) 9.81 (8.39) 9.47 (7.51) 9.91 (8.02)
Age at onset (years) 28.73 (10.36) 28.57 (9.90) 30.12 (8.96) 29.64 (10.14)
HDRS28 (baseline) 30.17 (4.71) 30.00 (4.72) 30.18 (4.93) 30.18 (4.49)
MADRS (baseline) 31.40 (5.70) 29.19 (4.19) 30.00 (4.21) 29.36 (4.63)
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rating, the items were transformed in the third person. The
NEO-FFI consists of five factors: neuroticism, extraversion, open-
ness to experience, agreeableness, and conscientiousness.
Depression was assessed with the HDRS (Hamilton, 1960) and
the Montgomery–Åsberg Depression Rating Scale (MADRS;
Montgomery & Asberg, 1979). Both instruments are observer-
rating depression scales and measure the severity of the depres-
sion in clinical samples. On the basis of these instruments, the
depression can be classified as mild, moderate, or severe.
Additionally, patients were asked in a half-standardized inter-
view if they perceive changes in personality since the onset of
DBS.
Statistical analysis
Depression outcome was analyzed using Student’s t test for de-
pendent samples comparing baseline v. t2, t3, and t4. Baseline
personality profiles were compared with a healthy normative sam-
ple with Student’s t test for one sample corrected for multiple
comparisons (Bonferroni correction). Change of personality was
analyzed using Student’s t test for paired samples comparing
baseline v. t2 (n = 21). This analysis was performed extra besides
analysis of variance (ANOVA) over all four time points, because
ANOVA can only include complete data sets. Change of person-
ality over four time points was analyzed with ANOVA for
repeated measures and the factor TIME (n = 14). Results are
reported with Greenhouse–Geisser correction, because of the
small sample size.
Correlation analyses of personality traits and severity of
depression were performed for the outcome 6 months after the
onset of DBS (t2) with Pearson’s correlation coefficient.
Analyses were performed for t2 because of small variance in
depression severity at baseline and because of small sample
sizes at t3 and t4 (n < 20). Baseline personality dimensions were
correlated with the reduction of depressive symptoms 6 months
after the onset of DBS for the evaluation of predictors of anti-
depressant response.
Reliability of the self- and observer ratings was analyzed with
Cronbach‘s α for the NEO-FFI. Patients and observers were com-
pared at baseline and at t4. Self- and observer ratings of each per-
sonality dimension were correlated using Spearman correlation
because of the small sample size. Finally, the average values of
self- and observer ratings were compared using Student’s t test
for paired samples.
Interviews were analyzed using qualitative content analysis
(Mayring, 2010).
Results
Demographic and clinical characteristics
The patients (n = 30; 13 women and 17 men) were in average 47
years old at the implantation (S.D. 10.62) and had a mean onset
age of the first depressive episode of 29 years (S.D. 10.36). The
mean length of current depressive episode was 8.6 years (S.D.
7.75). At t4, 11 patients were included at the long-term outcome.
Compared with the 30 patients at baseline, there is no significant
change seen in the demographic variables (Table 1).
Clinical outcomes
Depression
At baseline, the mean score of HDRS28 was 30.17 (S.D. 4.71) and
the mean score of MADRS was 31.40 (S.D. 5.70) both indicating
severe depressive symptoms. Six months after the onset of DBS
(t2), the mean score of HDRS28 [t(20) = 7.80; p < 0.001] and the
Fig. 1. Flow of patient number included from baseline to t4.
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mean score of MADRS [t(20) = 7.69; p < 0.001] were significantly
reduced compared with the baseline. At t3, HDRS28 [t(16) =
7.14; p < 0.001] and MADRS [t(16) = 7.227; p < 0.001] as well as
at t4 for both HDRS28 [t(10) = 5.38; p < 0.001] and MADRS
[t(10) = 6.40; p < 0.001], the reduction of severity of depression
was significant compared with the baseline scores (Fig. 2). At
t4, there was one non-responder, showing outlining scores
(HDRS = 40; MADRS = 34). The other 10 patients had an average
HDRS28 of 5.50 (S.D. 5.99) and MADRS of 6.90 (S.D. 7.75).
Personality
The personality profile of chronic, severe TRD patients (n = 30)
was compared with the healthy normative sample (M = 50;
S.D. = 10) (Fig. 3). At baseline, TRD patients showed significantly
reduced scores in extraversion [t(29) =−5.20; p < 0.001], openness
to experience [t(29) =−6.96; p < 0.001], and conscientiousness
[t(29) =−2.04; p < 0.05] as well as increased scores in neuroticism
[t(29) = 4.45; p < 0.001] and agreeableness [t(29) = 4.58; p < 0.001].
Comparing patients’ scores to standard values (t-values),
patients scored statistically significant lower in extraversion and
openness to experience. All other measures were within the
range of one standard deviation and thus not judged as clinically
deviant (>1 standard deviation lower than the mean).
No change was found in any personality dimension from base-
line to 6 months follow-up (t2) in the group analysis (n = 21)
(Table 2). The scores in neuroticism [F(2.29, 22.89) = 1.82; p > 0.05],
extraversion [F(2.09, 20.89) = 0.21; p > 0.05], openness to experience
[F(2.31, 23.11) = 0.14; p > 0.05], agreeableness [F(2.52, 25.18) = 1.09;
p > 0.05], and conscientiousness [F(2.52, 25.16) = 1.07; p > 0.05] (n
= 11) did not change significantly at any time point after the
onset of DBS.
Dropouts did not differ in baseline personality from study
terminators as assessed with t tests.
Personality and depression
Extraversion was negatively correlated with HDRS28 (r = −0.48,
p < 0.05) and MADRS (r =−0.45, p < 0.05) 6 months after the
onset of DBS (t2) (Fig. 4). Lower severity of depression was asso-
ciated with a higher score in extraversion (t2) but not with other
personality dimensions (Table 3).
None of the five dimensions of personality at baseline was able
to predict the antidepressant response as calculated in a correl-
ation analysis (Table 4).
Self- and observer rating of personality
In an explorative analysis, personality ratings of patients and their
relatives were assessed at baseline (n = 14) and at t4 (n = 9).
Cronbach’s α (α = 0.74) at baseline and at t4 (α = 0.65) demon-
strate a good inter-rater correlation between patients and their
relatives in NEO-FFI. The Spearmen non-parametric correlation
also demonstrated a significant positive correlation between rat-
ings at baseline (rs = 0.58; p < 0.001) and at t4 (rs = 0.49; p <
0.001). We refrained from inter-rater correlation sub-analyses of
dimensions because of the limited sample size.
Group analysis of differences in the mean scores showed sig-
nificant differences between the average rating of self- and obser-
ver rating only in agreeableness at baseline and in agreeableness
and conscientiousness at t4 as assessed with Student’s t test for
paired samples: patients rated themselves at baseline [t(13) =
4.60, p < 0.001] and at t4 [t(8) = 4.49; p < 0.01] as more agreeable
and less conscientious than their relative [t(8) = −2.52; p < 0.05].
See Figure 5a–e for a detailed descriptive analysis of the ratings
for the five dimensions of personality.
Discussion
In this study, we analyzed (1) the effect of DBS of the medial
forebrain bundle on the personality dimensions neuroticism,
extraversion, openness for experience, agreeableness, and con-
scientiousness in patients suffering from chronic, severe TRD.
Furthermore, we investigated (2) how personality, depression
severity, and the antidepressant response are associated and (3)
compared patients’ self-ratings of personality with observer rat-
ings to obtain information on the validity of self-ratings of depres-
sive patients.
Effect of DBS of the slMFB on personality
To our knowledge, this is the first study assessing effects of
DBS on personality in a standardized way. DBS was not associated
with a change in personality per se. There was no difference
between the dimensions of personality at baseline compared
with 6 months, 2 and 5 years after the onset of DBS. This is in
contrast to findings in STN-DBS in Parkinson’s disease where sig-
nificant changes in personal and socio-professional adjustment
(Schüpbach et al. 2006) as well as changes in patients’ thoughts
and personality (Glannon, 2009) have been reported. It is not
known, if these reported changes can be attributed to DBS per
Fig. 2. (a) Severity of depression (mean and standard deviation) as measured with
the Hamilton Depression Rating Scale (HDRS_28). Student’s t test, baseline v. t2,
t3, and t4; ***p < 0.001. (b). Severity of depression (mean and standard deviation)
as measured with the Montgomery–Asberg Depression Rating Scale (MADRS).
Student’s t test, baseline v. t2, t3, and t4; ***p < 0.001.
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se, to the response to a new situation, to a change in the severity of
Parkinson’s symptoms, or to a change in medication (e.g. tapering
down of dopamine agonists).
Furthermore, these findings in neurological indications have
contributed to a debate about ethical implications of DBS
(Schermer, 2011). A strong concern in public debates and in
patients applying for DBS is that DBS might alter their body con-
ceptualization, induce the ‘feeling of strangeness’, lead to a ‘bio-
graphic disruption’, or to a change in personality (Schüpbach
et al. 2006). Another question is how the patient himself perceives
the changes in personality, mood, behavior, or cognition – as dis-
ruptive and disturbing or as positive (Synofzik & Schlaepfer,
2008).
The stability of the personality profile with slMFB-DBS
demonstrated here can only be related to stimulation of the
present brain target, the slMFB. The slMFB is a key structure of
the reward system, mediating its effects by dopaminergic trans-
mission (Coenen et al. 2012). One function of dopamine is
promoting exploration behavior and it has been linked to extra-
version as well as reward sensitivity (DeYoung, 2013). DBS of
other targets might have a different influence on personality.
Association between personality and depression
There was no change of personality in the group analysis, but
extraversion showed an association with the severity of depressive
symptoms during DBS: extraversion and scores of HDRS and
MADRS were negatively correlated, indicating that patients who
had a lower severity of depression showed high scores on extraver-
sion. This finding is in line with studies reporting high
Fig. 3. Personality dimensions at baseline. TRD patients (n = 30)
compared with the healthy normative sample (mean and stand-
ard deviation). ***Clinically significant (more than one standard
deviation, S.D. 10). Data within the gray-shaded area are within
the range of the healthy normative sample.
Table 2. NEO-FFI personality scores at baseline and 6 months after the onset of DBS (t2)
n Mean S.D.
Paired samples t test
t df pMean change S.D. change
Neuroticism
Baseline 21 59.05 9.37 0.81 12.80 0.29 20 0.77
t2 21 58.24 11.33
Extraversion
Baseline 21 37.24 11.41 1.81 14.06 0.59 20 0.56
t2 21 35.43 12.42
Openness to experience
Baseline 21 38.19 9.88 0.14 8.87 0.07 20 0.94
t2 21 38.05 11.36
Agreeableness
Baseline 21 58.57 12.09 1.71 9.56 0.82 20 0.42
t2 21 56.86 9.33
Conscientiousness
Baseline 21 43.33 9.37 2.71 10.06 1.24 20 0.23
t2 21 40.62 6.79
Mean, number of patients in analysis (n), standard deviation (S.D.), two-tailed paired t test with scores at baseline and 6 months after the onset of DBS.
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correlations between personality dimensions and the severity of
depression (Chioqueta & Stiles, 2005; Jylhä & Isometsä, 2006).
It is discussed that whether an antidepressant treatment or the
antidepressant response can change the personality profile
(Costa et al. 2005; Klein et al. 2011; Karsten et al. 2012). In this
study, the personality profiles did not change systematically
with the antidepressant response. In favor of a scar effect of
depression are the following findings: extraversion was
significantly lower at baseline compared with the healthy norm
but did not change overall, although most patients responded to
the treatment. Patients were already depressed at baseline, thus
prospective long-term studies would be adequate to decide
between scar and state theories.
Previous studies have also demonstrated a correlation between
neuroticism and the severity of depression (Du et al. 2002;
Chioqueta & Stiles, 2005; Jylhä & Isometsä, 2006), which could
not be confirmed in this study. An explanation could be the lack
of clinically deviant scores of neuroticism at baseline, the high
response rate of patients, a small variance in the severity of depres-
sion, or the small sample size. It could also underline the scar
effect of depression on neuroticism. TRD patients have been suf-
fering from depression for a very long time [average of 8.6 years
(S.D. 7.75)]. The severity and chronicity of the depressive symp-
toms could explain the difference to studies reporting a change
of neuroticism if depressive symptoms are reduced (Corruble
et al. 2002; Du et al. 2002; De Fruyt et al. 2006; Tang et al.
2009). This hypothesis can be supported by a study that treated
TRD patients with repetitive transcranial magnetic stimulation
without any change of personality traits (McGirr et al. 2014).
In the current study, personality dimensions at baseline did
not predict the antidepressant response. Other studies reported
that higher scores in neuroticism and lower scores in extraversion
at baseline were associated with a smaller antidepressant effect
(Klein et al. 2011).
In this study, neuroticism was less increased than in other
studies of depressed patients and the response and remission
rate of patients was very high. These facts combined with the
small sample size could explain the lack of statistical significance
of our results.
Self-ratings and observer ratings
It is well known that self- and observer ratings are correlated in
the healthy population (Connolly et al. 2007). It is questioned,
if patients are able to judge their personality accurately during
an acute depressive episode because of a possible depression-
induced rating bias (Bagby et al. 1998; Klein et al. 2011). There
are only a few studies comparing self- and observer ratings of
depressive patients and their relatives (Riemann et al. 1997;
Bagby et al. 1998; McCrae et al. 2004). Bagby et al. (1998)
reported a very high correlation for most personality dimensions,
but differences between patients and relatives were seen in extra-
version. In the present sample, a good inter-rater reliability was
found between patients and their most significant relative (e.g.
partner, close friend) at baseline and also after 5 years of DBS.
This underscores that patients are able to judge their personality
in a depressive episode as well as during recovery. Only in the
dimension of agreeableness, patients scored themselves higher
than their relatives at baseline as well as after 5 years. Most studies
found decreased agreeableness in depressive patients (Kotov et al.
2010). Possibly, a selection bias could explain these results:
patients were selected when they seemed very compliant to the
study and many patients had good social skills and social support
in spite of the chronicity and severity of the disease.
Personality of depressive patients compared with the healthy
normative population
In this study, patients suffering from TRD differed statistically
from the healthy population in all five dimensions of personality.
Fig. 4. (a) Correlation analysis of extraversion and severity of depression. Pearson
correlation, extraversion × HDRS28 (r =−0.48, p < 0.05). (b) Correlation analysis of
extraversion and severity of depression. Pearson correlation, extraversion × MADRS
(r =−0.45, p < 0.05).
Table 3. Pearson correlation of personality traits and severity of depression (t2)
HDRS28 (t2) MADRS (t2)
n 21 21
NEO-FFI (t2)
Neuroticism 0.35 0.32
Extraversion −0.48* −0.45*
Openness to experience −0.37 −0.41
Agreeableness −0.26 −0.17
Conscientiousness −0.39 −0.32
*p < 0.05.
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In line with other studies, a typical personality profile of de-
pression with reduced extraversion, reduced conscientiousness,
and elevated neuroticism was found (Petersen et al. 2001;
Tang et al. 2009; Kotov et al. 2010). This broadens the results
from less severely affected patients also to treatment-resistant
patients.
Openness to experience and extraversion were reduced more
than one standard deviation from the mean of the healthy popu-
lation. The low score in openness to experience is discussed to be
specific for patients with TRD (Takahashi et al. 2013).
Possibly, the reduced extraversion and openness to experience
can be explained by the behavioral approach to depression by
Table 4. Personality dimensions at baseline as predictors of response (Pearson correlation)
Reduction of
depressive symptoms
HDRS28
t2 – baseline
MADRS
t2 – baseline
HDRS28
t3 – baseline
MADRS
t3 – baseline
HDRS28
t4 – baseline
MADRS
t4 – baseline
n 21 21 17 17 11 11
Neuroticism −0.13 −0.10 −0.18 −0.31 −0.22 −0.23
Extraversion −0.07 −0.09 0.01 0.11 −0.29 −0.16
Openness to experience −0.02 −0.13 0.05 0.00 0.03 0.01
Agreeableness 0.14 0.09 0.29 0.09 0.61 0.58
Conscientiousness 0.11 0.07 0.05 0.19 0.37 0.62
Fig. 5. (a–e) Average values (with standard deviation) of self- and
observer ratings compared with Student’s t test for paired samples.
In this analysis, only patients with a corresponding observer rating
could be included (n = 14). ***p < 0.001; **p < 0.01, *p < 0.05.
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Lewinsohn, hypothesizing a relationship between positive re-
inforcement and depression (Lewinsohn, 1974). The Lewinsohn’s
reward model of depression (1974) describes depression with a
reduction in the availability of positive, reinforcing stimuli and
less searching for new (positive) situations. These factors result
in less experience of reward as a key component for the develop-
ment and maintenance of depression.
Interestingly, the personality profile of TRD patients showed
less extreme deviations from the norm than one might expect
for severe, chronic depression (Petersen et al. 2001; Du et al.
2002; Cuijpers et al. 2005; Tang et al. 2009; Kotov et al. 2010).
Possibly, the personality profile in our sample could represent a
protective factor, because it allowed a better coping with a severe,
chronic depression. Higher scores in neuroticism have been asso-
ciated with a higher incidence of suicidal behavior in individuals
(Fergusson et al. 2000). Another explanation for the clinically
moderate deviance in the profile of personality could be a selec-
tion bias; patients with severe comorbidities and personality dis-
orders have been excluded from the study. Patients with comorbid
personality disorder and major depression as well as patients with
only the diagnosis of a personality disorder showed higher levels
of neuroticism than patients with only major depression (Morey
et al. 2010).
Ethical and practical implications
It could be demonstrated that DBS of the slMFB did not change
the personality profile, but personality was associated with the
severity of depression. Antidepressant treatments, including psy-
chotherapy and pharmacotherapy, aim to normalize symptoms
such as depressed mood, cognitive deficits, and lack of motiv-
ation, which are also discussed as central aspects of personality
(Synofzik & Schlaepfer, 2008). Tang et al. (2009) reported
changes of personality due to selective serotonin reuptake inhibi-
tors and due to cognitive therapy that were greater than with pla-
cebo medication. In this light, DBS of the slMFB can be
considered to be an effective antidepressant treatment method
without a manipulation of personality per se.
It is ethically relevant how patients judge possible changes
in personality associated with an antidepressant treatment
(Synofzik & Schlaepfer, 2008). After 5 years of DBS, patients
were asked in an explorative analysis how they perceived their per-
sonality during the study. Seven patients described positive
changes, while two patients described no personality changes.
Positive changes were an increase in ‘self-confidence’, ‘activity’
as well as ‘energy’, which were associated with the reduction of
depressive symptoms and which were experienced as ‘a return
to the person they were without depressive symptoms’.
The small sample size limits the generalizability of our results.
Nonetheless, we could replicate a relationship between high
levels in extraversion and low severity of depression. Because of
the exclusion of personality disorder and severe psychiatric
comorbidities (see Schlaepfer et al. 2013 for details on inclusion
and exclusion criteria) for details on inclusion and exclusion cri-
teria, this sample might not be representative for all severe TRD
patients where comorbidities are the rule (Fava, 2003). This
may explain some differences in results compared with less severe
and differently selected samples in other studies. On the other
hand, the present sample constituted of extremely treatment-
resistant patients and a large number of patients responded to
the treatment, so any scar or state effect of depression on person-
ality should be observable.
Conclusion
The present study demonstrates that DBS of the slMFB was
not associated with changes in personality dimensions of TRD
patients. In accordance to the literature, patients who were less
depressive with DBS showed higher levels of extraversion, similar
to the healthy population. The high inter-rater correlation
between patient’s self-description of personality with the descrip-
tion of their closest relative showed that patients are able to assess
their personality in an acute depressive episode.
Highlights
• DBS of the medial forebrain bundle does not change
personality.
• The severity of depression is correlated with extraversion but
not with neuroticism.
• Personality does not change with the antidepressant treatment
effect; this points towards a scar effect of depression.
• Patients differ from healthy subjects in their personality profile
and are similar to patients with milder forms of depression.
• TRD patients are able to judge their personality in a valid way.
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